Young Investigator Grants attract and train new minds and hearts for lymphoma research while accomplishing important research work in the labs of senior mentors and sponsors.
Disease-Specific Focus Areas grants are given to senior researchers conducting investigations in the following areas:
New focus area-specific grants are developed as financial resources become available. Requests for further information should be directed to firstname.lastname@example.org.
NOTE: Lymphoma Research Foundation reserves the right to change deadlines, forms, and guidelines, plus any and all details pertaining to grant availability, rules, eligibility criteria, selection process, etc. All LRF Research Grants are dependent on funding availability.
If you would like to learn more about how you can invest in lymphoma research, please click here.
Post-Doctoral Fellowships and Clinical Investigator Career Development Awards are central to our mission and represent our two Cornerstone Research Programs. These programs attract young physicians to the field of lymphoma and support their training in lymphoma and clinical research. LRF is proud that since 1992 we have awarded over 210 Fellowships, while since 2002, we have awarded 12 Clinical Career Development Awards. Our Lymphoma Clinical Research Mentoring Program, new for 2014, furthers our commitment to developing talented young investigators.
These two-year post-doctoral fellowships help attract the nation's best scientific talent to careers in lymphoma and allow them to pursue promising research leads under the guidance of a sponsor. These young researchers are at their peak in terms of innovation. They are working on questions and in labs where they are making significant contributions essential to a greater understanding of lymphoma as well as how to treat lymphoma effectively. Applicants must be affiliated with an institution in the U.S. or Canada. Fellowships are awarded $50,000 in year one and $55,000 in year two.
Clinical Investigator Career Development Awards
This three-year program (now with expanded eligibility) funds training of clinicians who will participate in developing new therapeutic and diagnostic tools for lymphoma. Clinicians will be trained to design and administer clinical studies and to take on primary responsibility for trial design, protocol development, IRB submission, and publication. A Career Development Plan and the commitment of a mentor are required as part of the grant application. Like the Fellowships, these early career physicians are not only learning, they are also discovering improved therapies. CDAs are awarded $75,000 per year for three years. Applicants must be licensed in the United States or Canada.
Open to advanced doctoral fellows and junior faculty, this program will select a group of LRF Scholars to receive mentoring and education dedicated to clinical research methods and design, statistical analysis, incorporating and interpreting correlative studies into clinical trials, and grant submission and funding, with the aim of fostering mentorship and research between experts and trainees in lymphoma research. Participants will attend a four day workshop in a small group setting consisting of experts in the field, statisticians, and other trainees in the program, where information, ideas, guidance, support, and connections are shared, and where mentoring relationships can be developed. The program includes a mini-grant of $5000 a year (for up to two years) to cover travel, conference fees, and other activities designed to further the Scholar's career development.
LRF supports research in several disease focus areas: chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), follicular lymphoma and mantle cell lymphoma (MCL). Grants have taken a variety of forms including "R01" type grants for senior researchers, collaborative grants across medical disciplines, correlative awards which enhance existing clinical studies, planning grants to develop a plan and supportive data designed to raise funds from government/other major funding sources, and exploratory/developmental grants to help develop a proof of concept, leading to another project and/or funding.
Announcements of grant availability, i.e. Requests for Proposals (RFPs), are made when funding becomes available. Therefore there may not be grants available in each category every year.
A sampling of past grant announcements:
Chronic Lymphocytic Leukemia (CLL) Collaborative Grant
This two-year CLL Collaborative Grant sought high quality research studies in CLL including the study of primary CLL patient samples to assure relevance to the human disease. In addition, applicants were required to explicitly delineate how the proposed research would incorporate collaborative interactions between/among investigators in different disciplines (e.g. pathology and medical oncology, basic science research and clinical investigators) and/or different institutions.
Diffuse Large B-Cell Lymphoma (DLBCL) Explorations Grant
This two-year DLBCL Explorations Grant sought applications which were expected to include the study of primary DLBCL patient samples. Proposals were to include a clear indication of how the project would be clinically relevant to the improvement of outcomes for patients with DLBCL. Applicants were encouraged to describe how they would leverage other resources (funding support, institutional resources, clinical trial samples, etc.) in carrying out the project. In addition, applicants were required to delineate how the proposed research project would involve collaborative interactions between/among investigators in different disciplines (e.g., pathology and hematology/oncology, basic science research & clinical investigators) and/or different institutions.
Follicular Lymphoma Research
The goal of LRF's Follicular Lymphoma (FL) Research Initiative is to develop novel therapeutic strategies for the treatment of FL. LRF sought proposals that advance the understanding of the human biology of FL or that verify molecular targets for FL therapeutics.
Correlative Clinical Studies Award
Applications to this initiative had to be adjunct to a major FL research project and work in the clinical setting or with primary FL patient samples.
LRF sought proposals for this 3-year Grant for high quality research studies in FL. Applications were required to include the study of primary FL patient samples to assure relevance to the human disease. In addition, applicants were required to explicitly delineate how the proposed research would incorporate collaborative interactions between/among investigators in different disciplines (e.g. pathology & medical oncology, basic science research & clinical investigators) and/or different institutions.
Mantle Cell Lymphoma (MCL) Research
In 2003, LRF started the Mantle Cell Lymphoma Initiative to accelerate the pace of research in mantle cell lymphoma (MCL). LRF-funded MCL research projects have ranged from laboratory studies to the identification of new therapeutic approaches, including clinical trials of novel agents, chemo immunotherapy, radiation therapy and stem cell transplantation. The grant types described above for CLL, DLBCL and FL have also been offered for MCL. Future MCL grant opportunities are dependent on the availability of funds.
For more information on active grants and the application process, please see the following: